Hajime Onuma

Lactate dehydrogenase predicts combined progression‐free survival after sequential therapy with abiraterone and enzalutamide for patients with castration‐resistant prostate cancer

Keiichiro Mori, Takahiro Kimura, Hajime Onuma et al. · The Prostate · 2017 · 34 citations

Medicine, Oncology, Pharmacotherapy +17

Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer

Shun Sato, Takahiro Kimura, Hajime Onuma et al. · BJUI Compass · 2020 · 34 citations · Full text

Medicine, Oncology, Urology +17

Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events

Michie Katsuta, TAKAHIRO KIMURA, Kojiro Tashiro et al. · Anticancer Research · 2022 · 26 citations

Medicine, Oncology, Pharmacology +13

Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer

Takafumi Yanagisawa, Takahiro Kimura, Keiichiro Mori et al. · The Prostate · 2021 · 23 citations

Medicine, Oncology, Urology +17

Cases Having a Gleason Score 3+4=7 With <5% of Gleason Pattern 4 in Prostate Needle Biopsy Show Similar Failure-free Survival and Adverse Pathology Prevalence to Gleason Score 6 Cases in a Radical Prostatectomy Cohort

Shun Sato, Takahiro Kimura, Takashi Yorozu et al. · The American Journal of Surgical Pathology · 2019 · 22 citations

Medicine, Pathology, Urology +17